Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Troussard

Showing results (31-40 of 365) with videos related to

Pageof 37
Sort By:
Blood|January 27, 2012
Persistent polyclonal B-cell lymphocytosisJean Francois Lesesve, Xavier Troussard
International Journal of Laboratory Hematology|April 30, 2015
Contribution of the new XN-1000 parameters NEUT-RI and NEUT-WY for managing patients with immature granulocytesE Cornet, M Boubaya, X Troussard
Bulletin Du Cancer|May 23, 2021
[Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]Xavier Troussard, Elsa Maitre, Jérôme Paillassa
International Journal of Laboratory Hematology|October 29, 2015
Comparative study of quantitative performances between the new Sysmex XN-L (XN-550) haematology analyser and the XN-9000 in a routine laboratoryC Geara, E Cornet, X Troussard
Current Oncology Reports|April 11, 2022
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic AdvancesJérôme Paillassa, Elsa Maitre, Xavier Troussard
Hematology and Cell Therapy|October 10, 1998
Hairy cell leukemia. What is new forty years after the first description?X Troussard, F Maloisel, G Flandrin
Bulletin Du Cancer|January 1, 1992
[Multiple myeloma: current therapeutic approaches]X Troussard, F Bauduer, M Leporrier
Bulletin Du Cancer|December 1, 1993
[Prognostic factors in multiple myeloma. Review of the literature]F Bauduer, X Troussard, A Delmer
Journal of Cellular and Molecular Medicine|August 2, 2023
Hairy cell leukaemia with unusual BRAF mutationsElsa Maitre, Margaret Macro, Xavier Troussard
American Journal of Hematology|October 28, 2021
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatmentXavier Troussard, Elsa Maître, Edouard Cornet
Pageof 37

Showing results (31-40 of 365) with videos related to

Sort By:
Pageof 37
Blood|January 27, 2012
Persistent polyclonal B-cell lymphocytosisJean Francois Lesesve, Xavier Troussard
International Journal of Laboratory Hematology|April 30, 2015
Contribution of the new XN-1000 parameters NEUT-RI and NEUT-WY for managing patients with immature granulocytesE Cornet, M Boubaya, X Troussard
Bulletin Du Cancer|May 23, 2021
[Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]Xavier Troussard, Elsa Maitre, Jérôme Paillassa
International Journal of Laboratory Hematology|October 29, 2015
Comparative study of quantitative performances between the new Sysmex XN-L (XN-550) haematology analyser and the XN-9000 in a routine laboratoryC Geara, E Cornet, X Troussard
Current Oncology Reports|April 11, 2022
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic AdvancesJérôme Paillassa, Elsa Maitre, Xavier Troussard
Hematology and Cell Therapy|October 10, 1998
Hairy cell leukemia. What is new forty years after the first description?X Troussard, F Maloisel, G Flandrin
Bulletin Du Cancer|January 1, 1992
[Multiple myeloma: current therapeutic approaches]X Troussard, F Bauduer, M Leporrier
Bulletin Du Cancer|December 1, 1993
[Prognostic factors in multiple myeloma. Review of the literature]F Bauduer, X Troussard, A Delmer
Journal of Cellular and Molecular Medicine|August 2, 2023
Hairy cell leukaemia with unusual BRAF mutationsElsa Maitre, Margaret Macro, Xavier Troussard
American Journal of Hematology|October 28, 2021
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatmentXavier Troussard, Elsa Maître, Edouard Cornet
Pageof 37